ArticleDrug safety2025

An Evaluation of Duplicate Adverse Event Reports Characteristics in the Food and Drug Administration Adverse Event Reporting System.

Scott Janiczak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.